Oncology Nursing Practice Patterns in Multiple Myeloma.
- Published in:
- 2009
- By:
- Publication type:
- Conference Paper/Materials
Works matching DE "MILLENNIUM Pharmaceuticals Inc."
Results: 31
1
2
Pipeline preview.
- Published in:
- Formulary, 2008, v. 43, n. 3, p. 91
- Publication type:
- Article
3
Product Preview.
- Published in:
- Urology Times, 2004, v. 32, n. 1, p. 24
- Publication type:
- Article
4
Chemotherapy Response Markers To Enter Trials.
- Published in:
- PharmaGenomics, 2003, v. 3, n. 2, p. 13
- Publication type:
- Article
5
Takeda buys Millennium Pharma.
- Published in:
- TCE: The Chemical Engineer, 2008, n. 803, p. 8
- Publication type:
- Article
6
Good vibrations.
- Published in:
- Nature Medicine, 2011, v. 17, n. 7, p. 768, doi. 10.1038/nm0711-768
- By:
- Publication type:
- Article
7
Combo Confusion.
- Published in:
- Bio-IT World, 2006, v. 5, n. 1, p. 30
- By:
- Publication type:
- Article
8
Dharmacon Signs Library Deal.
- Published in:
- Bio-IT World, 2005, v. 4, n. 6, p. 30
- By:
- Publication type:
- Article
9
Imaging in the New Millennium.
- Published in:
- Bio-IT World, 2005, v. 4, n. 5, p. 1
- By:
- Publication type:
- Article
10
On the Up and Up.
- Published in:
- Bio-IT World, 2004, v. 3, n. 2, p. 32
- By:
- Publication type:
- Article
11
Applications: Unbreakable vs. Disposable.
- Published in:
- Bio-IT World, 2003, v. 2, n. 12, p. 18
- By:
- Publication type:
- Article
12
RECOMBINATION.
- Published in:
- Bio-IT World, 2003, v. 2, n. 8, p. 18
- Publication type:
- Article
13
Millenium's PARIS Illuminates Pathways.
- Published in:
- Bio-IT World, 2003, v. 2, n. 7, p. 55
- Publication type:
- Article
14
MILLENNIUM STANDS FIRM ON RISKY PHARMACOGENOMICS STRATEGY.
- Published in:
- Bio-IT World, 2003, v. 2, n. 2, p. 1
- By:
- Publication type:
- Article
15
Joseph Bolen.
- Published in:
- 2009
- By:
- Publication type:
- Interview
16
Alemtuzumab (Campath 1-H).
- Published in:
- Clinical Journal of Oncology Nursing, 2005, v. 9, n. 5, p. 630, doi. 10.1188/05.CJON.630-632
- By:
- Publication type:
- Article
17
Monsanto links up with Millennium on genome research.
- Published in:
- Nature, 1997, v. 390, n. 6655, p. 5, doi. 10.1038/36168
- By:
- Publication type:
- Article
18
Business Digest.
- Published in:
- Chemistry & Industry, 2008, n. 11, p. 15
- By:
- Publication type:
- Article
19
Job losses hit Millennium.
- Published in:
- Chemistry & Industry, 2003, n. 12, p. 5
- Publication type:
- Article
20
US Financial accounts reports.
- Published in:
- Journal of Commercial Biotechnology, 2001, v. 7, n. 3, p. 279, doi. 10.5912/jcb393
- By:
- Publication type:
- Article
21
PDL's mAb technology finds right timing.
- Published in:
- Nature Biotechnology, 2001, v. 19, n. 5, p. 395, doi. 10.1038/88010
- By:
- Publication type:
- Article
22
Recent patents in genomics.
- Published in:
- Nature Biotechnology, 2000, v. 18, n. 6, p. 685, doi. 10.1038/76550
- Publication type:
- Article
23
Millennium mergers bring pipeline.
- Published in:
- Nature Biotechnology, 1999, v. 17, n. 12, p. 1151, doi. 10.1038/70687
- By:
- Publication type:
- Article
24
Genomics companies strike a deal.
- Published in:
- Nature Biotechnology, 1999, v. 17, n. 11, p. 1048, doi. 10.1038/15002
- Publication type:
- Article
25
PEOPLE.
- Published in:
- Nature Biotechnology, 1999, v. 17, n. 7, p. 724, doi. 10.1038/10947
- Publication type:
- Article
26
Bayer's Millennium deal signals shift in R&D.
- Published in:
- Nature Biotechnology, 1998, v. 16, n. 11, p. 1005, doi. 10.1038/3449
- By:
- Publication type:
- Article
27
Multiple Myeloma Trial Stopped Early Due to Significant Efficacy Advantage of Bortezomib.
- Published in:
- Oncology (08909091), 2007, v. 21, n. 11, p. 1402
- Publication type:
- Article
28
MODEL OF CO-DEVELOPMENT EMERGES.
- Published in:
- Research Technology Management, 2002, v. 45, n. 3, p. 47, doi. 10.1080/08956308.2002.11671500
- By:
- Publication type:
- Article
29
Pharmaceutical Wannabe Emphasizes Productivity.
- Published in:
- Research Technology Management, 2001, v. 44, n. 6, p. 6
- By:
- Publication type:
- Article
30
Syntheses of C-13 and C-14-labeled versions of the investigational proteasome inhibitor MLN9708.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2013, v. 56, n. 9/10, p. 464, doi. 10.1002/jlcr.3079
- By:
- Publication type:
- Article
31
News.
- Published in:
- European Journal of Cancer Care, 2003, v. 12, n. 4, p. 302, doi. 10.1046/j.1365-2354.2003.00452.x
- Publication type:
- Article